Eucarbon Tablets Mild Herbal Laxative

Eucarbon belong to group of laxatives known as ( Contact laxatives ), it contains senna leaves and rhubarb root which accelerate the pancreas, activate the secretion of water and electrolytes into the intestinal lumen and reduce the absorption of electrolytes from the intestine thus soften the stool .it is aslo contain Wood charcoal which binds any possibly existing toxins. Eucarbon also even has a slightly disinfectant effect in the digestive tract.

Qualitative and quantitative composition

Each tablet contains the following Active ingredients:

Senna leaves (Folium Sennae) … 105 mg

Adjusted rhubarb extract (Extractum Rhei plv.)… 25 mg

Vegetable Charcoal (Carbo ligni) … 180 mg

Sulfur sublimed (Sulfur depuratum) …  50 mg

Pharmaceutical form

Gray-black, cylindrical, biconvex tablets .

Clinical data

Area of application

Traditional herbal medicine for treatment of occasionally occurring constipation.

This medicine is a traditional herbal medicine, registered solely based on long-term use for the mentioned application area.

Eucarbon can be used by children older than 12 years and adults.

Dosage, method and duration of use

For oral use, with plenty of liquid (at least a glass of water) before or after meals.

Adults and children over 12 years: 1 – 2 -tablets up to 3 times daily to achieve a mild laxative effect.

If a stronger laxative effect is desired, the evening dose can be increased to 3 – 4 tablets.

The application should be carried out only when it is needed and not on a regular basis.

Long-term use like 1.-2 weeks requires medical supervision.

Contraindications

Hypersensitivity to the active agents or to any of the ingredients .

Intestinal obstruction or stenosis

Acute inflammatory bowel disease, Crohn’s disease,or ulcerative colitis

Abdominal pain of unknown origin

Severe disorders of the fluid and electrolyte balance

Children under 12 years.

Special warnings and precautions for use

Sulphite warning: Sulfur may converted in the gut to alkali sulphites which may cause allergic type reactions including anaphylactic symptoms and life­threatening or less severe asthmatic episodes in certain susceptible people. Sulfite sensitivity is seen more frequently in asthmatic than in non asthmatic people.

Sucrose: Patients with rare hereditary problems of fructose _ intolerance, glucosegalactose malabsorption or  sucraseisomaltase insufficiency should not take this medicine.

The dose required for a guaranteed effect may vary individually.

Occurrence of diarrhea is a sign of overdose. In this case, the dose needs to be reduced  or the drug needs to be discontinued completely.

In case of unclear gastrointestinal symptoms with pain, nausea or vomiting, the cause needs to be clarified and the intestinal closure excluded before taking.

It cannot be taken without medical prescription over a longer period of time more than 1 to 2 weeks.

If the product is used continuously for a long time, the efficiency may be reduced.

Not suitable as a weight loss aid.

If there is a regular need for laxatives, the constipation cause has to be clarified.

The application .should generally only take place if a sufficient therapeutic effect cannot be achieved by a dietary change.

Patients with renal impairment need to be careful because this could increase the water and electrolyte imbalance.

Interactions with other medicines

In case of a hypokalemia caused by Eucarbon, the effect of cardiac glycosides is enhanced.

Interactions may also occur with antiarrhythmic drugs and medicines that cause extension of the QT interval.

Concomitant use of medicines which may also cause hypokalemia (e.g., diuretics, corticosteroids, or sweet tooth roots) may increase the electrolyte imbalance.

Fertility, pregnancy and lactation period

Use during pregnancy and lactation is not recommended.

Fertility data are not available.

Effects on the ability to drive and use machines

Eucarbon has no or negligible influence on the ability to drive and use machines.

Side effects

The following classification was used for the frequency descriptions of the side effects:

Very common :  > 1/10 .

Common : > 1/1000 and < 1/100 .

Uncommon : > 1/10 000 and < 1/1000 .

Rare : > 1/10000 and < 1/1 000

Very rare : < 1/10000, including individual cases.

Gastrolntestinal tract disorders

Abdominal pain, abdominal cramps and diarrhea usually occur only in patients with irritable colon or in case of a too high dosage. In this case, the dose needs to be reduced.

Allergic reactions can occur rarely.

Anthraquinone laxatives have rarely been described as central causes of nausea and vomiting; this cannot be ruled out even for senna leaves and rhubarb root. When it is used in high doses over long periods of time, electrolyte losses can occur, particularly potassium losses, which can further increase the intestinal inertia (intestinal atony and constipation).

Renal and urinary disorders

Slight red coloring of the urine can occasionally be observed due to its alkaline reaction and is without clinical relevance.

Overdose

The occurrence of diarrhea is an indication of overdose, the medicine needs to be either discontinued or the dosage reduced.

Misuse (overdose or long-term use) can lead to severe electrolyte imbalance.

Chronic abuse can lead to the occurrence of toxic hepatitis.

Pharmacological properties

Eucarbon belong to group of laxatives known as ( Contact laxatives ), The hydroxyanthracene derivatives from senna leaves and rhubarb root accelerate the pancreas, activate the secretion of water and electrolytes into the intestinal lumen and reduce the absorption of electrolytes from the intestine thus soften the stool . Wood charcoal binds any possibly existing toxins. Eucarbon also even has a slightly disinfectant effect in the digestive tract.

The laxative effect begins approximately 8 – 10 hours after the intake of Eucarbon tablets.

In a small number of patients with constipation within the scope of the irritable bowel syndrome (IBS), there are favorable experiences with the use of EUCARBON.

Pharmacokinetic properties

Special studies with Eucarbon tablets have not been conducted.

Preclinical safety data

Special studies with Eucarbon tablets have not been conducted.

Pharmaceutical data

List of the other Ingredients

Peppermint oil, fennel oil, sucrose, gum arabic, heavy kaolin, talc.

Incompatlblies

Not applicable.

Special storage precautions

Keep at temperature not exceeding 30° C.

Type and content of the container

Carton box contains 2 (AUPVC red) strips each of 10 tablets with insert leaflet.

Carton box contains 3 (AUPVC red) strips each of 10 tablets with insert leaflet.

Carton box contains 10 (AUPVC red) strips each of 10 tablets with insert leaflet.

Additional information

Produced by : South Egypt Drug Industries Company – SEDlCO .

Under licence of TRENKA Chemical pharmaceutical F· Trenka Vaenna • Austria.

patient information leaflet : scalable picture

eucarbon patient information leaflet
eucarbon patient information leaflet

PDF TO DOWNLOAD

Eucarbon tablet : patient information leaflet ( english ).

Eucarbon tablet : patient information leaflet ( arabic).

أضف تعليقك

لن يتم نشر عنوان بريدك الإلكتروني. الحقول الإلزامية مشار إليها بـ *